TECHNOLOGY FOCUS - INORGANIC CHEMISTRY - Preferred Component: The salt comprises sodium chloride, sodium phosphate, calcium phosphate, calcium carbonate, potassium phosphate, potassium sulfate, potassium chloride, potassium iodide, magnesium oxide, manganese carbonate, citric acid, ferric citrate, zinc carbonate, and/or cupric carbonate, preferably the salt comprises (wt.%) sodium chloride (3), sodium phosphate (2), calcium phosphate (73), calcium carbonate (2), potassium phosphate (8), magnesium oxide (2), and potassium sulfate (7). Salinity of the saline solution is 10-45 ppt.    TECHNOLOGY FOCUS - ORGANIC CHEMISTRY - Preferred Component: The bulk ingredient comprises flour, gluten, Alphacel (RTM: powdered cellulose), casein, and/or starch. The binder comprises albumin, lecithin, and/or starch. The dry base further comprises nutritional supplement comprising flour, albumin, starch, casein, and/or lecithin. The oily compound comprises fish oil, and/or vegetable oil. The preparation also comprises solvent consisting of ethanol and/or dimethyl sulfoxide.    TECHNOLOGY FOCUS - PHARMACEUTICALS - Preferred Component: The composition further comprises attractant comprising lecithin, casein, vitamin E acetate, cholesterol, fish extract, fish by-product, crustacean extract, crustacean byproduct, and/or organic matter; and vitamin comprising inositol, ascorbic acid, p-aminobenzoic acid, niacin, D-calcium, riboflavin, folic acid, thiamine mononitrate, pyridoxine hydrochloride, butylated hydroxyanisole, biotin, and/or vitamin B12. The composition comprises dry base (5-90, preferably 1-90 pts.wt.), viscous additive (10 pts.wt.), salt (5 pts.wt.), and not greater than 0.001 wt.% methyl farnesoate. The preparation further comprises a pre-liposome comprising L- alpha -phosphatidylcholine beta -oleoyl- gamma -palmitoyl and cholesterol. The composition has 12-25 (preferably 5-18)% moisture content, and 7.8-8 pH value. Preferred Method: The preparation of composition further comprises forming the preparation by vigorously agitating methyl farnesoate, pre-liposome and solvent; forming the composition into particles; drying the particles at not greater than 50 degrees C; and coating the particles. The second mixture is formed by adding second portion of saline solution to the preparation. The particles are dispensed at 2 g/ft2 before or after flooding the field with water, where density of particles is greater than that of water. ACTIVITY - None given.    MECHANISM OF ACTION - None given.    EXAMPLE - No suitable example given.